Europe Bladder Disorders Market - Industry Trends and Forecast to 2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	159 Pages	Data Bridge Market Research	September, 2022	DAABD17403900

Best Price Guarantee
Price	from $3,500
Length	159 Pages
Publisher	Data Bridge Market Research
Published Date	September, 2022
SKU	DAABD17403900

Europe Bladder Disorders Market - Industry Trends and Forecast to 2029

The Europe bladder disorders market is projected to register a substantial CAGR of 10.7% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2020, and the forecast period is 2022 to 2029

Market Segmentation
Europe Bladder disorders Market - By Type (Cystitis, Urinary Incontinence, Overactive Bladder, Interstitial Cystitis, Bladder Cancer), Treatment Type (Surgery, Medication, Non-surgical), End User (Hospitals, Clinics, Ambulatory Surgery Centres, Others), Distribution Channel (Direct, Retail), Country (Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium Rest of Europe) – Industry Trends and Forecast to 2029

Some of the major factors contributing to the growth of the Europe bladder disorders market are:
• Rising R&D investments and Launch of novel therapies in upcoming years
• Growing technological advancement
• Growing geriatric population
• Strategic initiatives adopted by market players
• High prevalence of bladder disorders

Market Players

The major companies which are operating in the Europe bladder disorders market are listed below:
• Medtronic
• Laborie
• Boston Scientific Corporation
• Pfizer Inc.
• Astellas Pharma Inc.
• KYORIN Pharmaceutical Co., Ltd. (A subsidiary of KYORIN Holdings, Inc.)
• Bristol-Myers Squibb Company
• Johnson & Johnson Services, Inc.
• Axonics, Inc.
• Merck & Co., Inc.
• Viatris Inc.
• Blue Wind Medical
• Valencia Technologies
• Gaylord Chemical Company, L.L.C.
• Coloplast Corp, AbbVie Inc.
• Sun Pharmaceutical Industries Ltd.
• Zydus Group
• Urovant Sciences, among others.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of Europe Bladder Disorders Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Type Lifeline Curve; 2.8 Primary Interviews With Key Opinion Leaders; 2.9 Dbmr Market Position Grid; 2.10 Market End User Coverage Grid; 2.11 Vendor Share Analysis; 2.12 Secondary Sources; 2.13 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porter's Five Forces; 4.3 Europe Bladder Disorders Market, Pipeline Analysis
5 Europe Bladder Disorder Market: Regulations: 5.1 The U.S. Regulatory Framework For Bladder Disoreder Medication; 5.2 Europe Regulatory Framework For Bladder Disorder Drugs; 5.3 Japan Regulatory Guidance On Bladder Disorder Drugs
6 Europe Bladder Disorders Market Overview: 6.1 Drivers; 6.1.1 Strategic Initiatives Adopted By Market Players; 6.1.2 Growing Geriatric Population; 6.1.3 Rising R&D Investments And Launch Of Novel Therapies In Upcoming Years; 6.1.4 Combination Of Different Target Therapies; 6.2 Restraints; 6.2.1 High Cost Associated With Bladder Disorder Diagnostic Treatment; 6.2.2 Products Recalls From Market; 6.3 Opportunities; 6.3.1 Surge In Novel Technological Advancements; 6.3.2 Rising Disease Management Programs; 6.4 Challenges; 6.4.1 Lack Of Awareness About Bladder Disorders Related Problems; 6.4.2 Patent Expiry Of Drugs
7 Europe Bladder Disorders Market, By Type: 7.1 Overview; 7.2 Overactive Bladder; 7.3 Urinary Incontinence; 7.4 Cystitis; 7.5 Interstitial Cystitis; 7.6 Bladder Cancer; 7.7 Others
8 Europe Bladder Disorders Market, By Treatment Type: 8.1 Overview; 8.2 Medication; 8.2.1 Tolterodine; 8.2.2 Mirabegron; 8.2.3 Fesoterodine; 8.2.4 Oxybutynin; 8.2.5 Solifenacin; 8.2.6 Darifenacin; 8.2.7 Trospium; 8.2.8 Others; 8.3 Surgery; 8.3.1 Surgery To Increase Bladder Capacity; 8.3.2 Bladder Removal; 8.3.3 Others; 8.4 Others
9 Europe Bladder Disorders Market, By Distribution Channel: 9.1 Overview; 9.2 Direct; 9.3 Retail
10 Europe Bladder Disorders Market, By End User: 10.1 Overview; 10.2 Hospitals; 10.3 Clinics; 10.4 Ambulatory Surgical Centers; 10.5 Others
11 Europe Bladder Disorders Market, By Geography: 11.1 Europe; 11.1.1 Germany; 11.1.2 U.K.; 11.1.3 France; 11.1.4 Italy; 11.1.5 Spain; 11.1.6 Turkey; 11.1.7 Russia; 11.1.8 Netherlands; 11.1.9 Switzerland; 11.1.10 Belgium; 11.1.11 Rest Of Europe
12 Europe Bladder Disorders Market: Company Landscape: 12.1 Company Share Analysis: Europe
13 Swot Analysis
14 Company Profile: 14.1 Merck And Co. Inc. (2021); 14.1.1 Company Snapshot; 14.1.2 Revenue Analysis; 14.1.3 Company Share Analysis; 14.1.4 Product Portfolio; 14.1.5 Recent Development; 14.2 Astellas Pharma Inc. (2021); 14.2.1 Company Snapshot; 14.2.2 Revenue Analysis; 14.2.3 Company Share Analysis; 14.2.4 Product Portfolio; 14.2.5 Recent Developments; 14.3 Bristol-myers Squibb Company (2021); 14.3.1 Company Snapshot; 14.3.2 Revenue Analysis; 14.3.3 Company Share Analysis; 14.3.4 Product Portfolio; 14.3.5 Recent Development; 14.4 Boston Scientific Corporation (2021); 14.4.1 Company Snapshot; 14.4.2 Revenue Analysis; 14.4.3 Company Share Analysis; 14.4.4 Product Portfolio; 14.4.5 Recent Development; 14.5 Viatris Inc. (2021); 14.5.1 Company Snapshot; 14.5.2 Revenue Analysis; 14.5.3 Company Share Analysis; 14.5.4 Product Portfolio; 14.5.5 Recent Development; 14.6 Abbvie (2021); 14.6.1 Company Snapshot; 14.6.2 Revenue Analysis; 14.6.3 Product Portfolio; 14.6.4 Recent Development; 14.7 Axonics, Inc. (2021); 14.7.1 Company Snapshot; 14.7.2 Revenue Analysis; 14.7.3 Product Portfolio; 14.7.4 Recent Development; 14.8 Blue Wind Medical (2021); 14.8.1 Company Snapshot; 14.8.2 Product Portfolio; 14.8.3 Recent Development; 14.9 Coloplast Corp. (2021); 14.9.1 Company Snapshot; 14.9.2 Revenue Analysis; 14.9.3 Product Portfolio; 14.10 Gaylord Chemical Company, Llc (2021); 14.10.1 Company Snapshot; 14.10.2 Product Portfolio; 14.10.3 Recent Development; 14.11 Johnson & Johnson Services, Inc. (2021); 14.11.1 Company Snapshot; 14.11.2 Revenue Analysis; 14.11.3 Product Portfolio; 14.11.4 Recent Development; 14.12 Kyorin Pharmaceutical Co., Ltd. (A Subsidiary Of Kyorin Holdings, Inc.) (2021); 14.12.1 Company Snapshot; 14.12.2 Product Portfolio; 14.12.3 Recent Developments; 14.13 Laborie (2021); 14.13.1 Company Snapshot; 14.13.2 Product Portfolio; 14.13.3 Recent Development; 14.14 Medtronic (2021); 14.14.1 Company Snapshot; 14.14.2 Revenue Analysis; 14.14.3 Product Portfolio; 14.14.4 Recent Developments; 14.15 Pfizer Inc. (2021); 14.15.1 Company Snapshot; 14.15.2 Revenue Analysis; 14.15.3 Product Portfolio; 14.15.4 Recent Developments; 14.16 Valencia Technologies (2021); 14.16.1 Company Snapshot; 14.16.2 Product Portfolio; 14.16.3 Recent Development; 14.17 Sun Phamaceutical Industries Ltd. (2021); 14.17.1 Company Snapshot; 14.17.2 Revenue Analysis; 14.17.3 Product Portfolio; 14.17.4 Recent Development; 14.18 Swati Spentose (2021); 14.18.1 Company Snapshot; 14.18.2 Product Portfolio; 14.18.3 Recent Development; 14.19 Urovant Sciences (2021); 14.19.1 Company Snapshot; 14.19.2 Product Portfolio; 14.19.3 Recent Development; 14.20 Zydus Group (2021); 14.20.1 Company Snapshot; 14.20.2 Product Portfolio; 14.20.3 Recent Development
15 Questionnaire
16 Related Reports 159
List Of Tables: Table 1 Europe Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 2 Europe Overactive Bladder In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 3 Europe Urinary Incontinence In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 4 Europe Cystitis In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 5 Europe Interstitial Cystitis In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 6 Europe Bladder Cancer In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 7 Europe Others In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 8 Europe Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 9 Europe Medication In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 10 Europe Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 11 Europe Surgery In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 12 Europe Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 13 Europe Others In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 14 Europe Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 15 Europe Direct In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 16 Europe Retail In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 17 Europe Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 18 Europe Hospitals In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 19 Europe Clinics In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 20 Europe Ambulatory Surgical Centers In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 21 Europe Others In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 22 Europe Bladder Disorders Market, By Country, 2020-2029 (Usd Million); Table 23 Europe Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 24 Europe Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 25 Europe Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 26 Europe Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 27 Europe Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 28 Europe Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 29 Germany Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 30 Germany Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 31 Germany Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 32 Germany Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 33 Germany Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 34 Germany Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 35 U.K. Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 36 U.K. Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 37 U.K. Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 38 U.K. Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 39 U.K. Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 40 U.K. Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 41 France Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 42 France Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 43 France Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 44 France Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 45 France Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 46 France Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 47 Italy Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 48 Italy Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 49 Italy Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 50 Italy Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 51 Italy Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 52 Italy Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 53 Spain Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 54 Spain Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 55 Spain Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 56 Spain. Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 57 Spain Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 58 Spain Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 59 Turkey Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 60 Turkey Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 61 Turkey Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 62 Turkey Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 63 Turkey Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 64 Turkey Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 65 Russia Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 66 Russia Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 67 Russia Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 68 Russia Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 69 Russia Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 70 Russia Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 71 Netherlands Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 72 Netherlands Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 73 Netherlands Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 74 Netherlands Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 75 Netherlands Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 76 Netherlands Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 77 Switzerland Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 78 Switzerland Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 79 Switzerland Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 80 Switzerland Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 81 Switzerland Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 82 Switzerland Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 83 Belgium Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 84 Belgium Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 85 Belgium Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 86 Belgium Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 87 Belgium Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 88 Belgium Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 89 Rest Of Europe Bladder Disorders Market, By Type, 2020-2029 (Usd Million) 110
List Of Figures: Figure 1 Europe Bladder Disorders Market: Segmentation; Figure 2 Europe Bladder Disorders Market: Data Triangulation; Figure 3 Europe Bladder Disorders Market: Droc Analysis; Figure 4 Europe Bladder Disorders Market: Europe Vs Regional Market Analysis; Figure 5 Europe Bladder Disorders Market: Company Research Analysis; Figure 6 Europe Bladder Disorders Market: Interview Demographics; Figure 7 Europe Bladder Disorders Market: Dbmr Market Position Grid; Figure 8 Europe Bladder Disorders Market: Market End User Coverage Grid; Figure 9 Europe Bladder Disorders Market: Vendor Share Analysis; Figure 10 Europe Bladder Disorders Market: Segmentation; Figure 11 Rising Epidemic And Pandemic Outbreak And Increasing Prevalence Of Bladder Disorders Expected To Drive The Europe Bladder Disorders Market In The Forecast Period Of 2022 To 2029; Figure 12 Overactive Bladder Segment Is Expected To Account For The Largest Share Of The Europe Bladder Disorders Market In 2022 & 2029; Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Europe Bladder Disorder Market; Figure 14 Europe Bladder Disorders Market: By Type, 2021; Figure 15 Europe Bladder Disorders Market: By Type, 2022-2029 (Usd Million); Figure 16 Europe Bladder Disorders Market: By Type, Cagr (2022-2029); Figure 17 Europe Bladder Disorders Market: By Type, Lifeline Curve; Figure 18 Europe Bladder Disorders Market: By Treatment Type, 2021; Figure 19 Europe Bladder Disorders Market: By Treatment Type, 2022-2029 (Usd Million); Figure 20 Europe Bladder Disorders Market: By Treatment Type, Cagr (2022-2029); Figure 21 Europe Bladder Disorders Market: By Treatment Type, Lifeline Curve; Figure 22 Europe Bladder Disorders Market: By Distribution Channel, 2021; Figure 23 Europe Bladder Disorders Market: By Distribution Channel, 2022-2029 (Usd Million); Figure 24 Europe Bladder Disorders Market: By Distribution Channel, Cagr (2022-2029); Figure 25 Europe Bladder Disorders Market: By Distribution Channel, Lifeline Curve; Figure 26 Europe Bladder Disorders Market: By End User, 2021; Figure 27 Europe Bladder Disorders Market: By End User, 2022-2029 (Usd Million); Figure 28 Europe Bladder Disorders Market: By End User, Cagr (2022-2029); Figure 29 Europe Bladder Disorders Market: By End User, Lifeline Curve; Figure 30 Europe Bladder Disorders Market: Snapshot (2021); Figure 31 Europe Bladder Disorders Market: By Country (2021); Figure 32 Europe Bladder Disorders Market: By Country (2022 & 2029); Figure 33 Europe Bladder Disorders Market: By Country (2021 & 2029); Figure 34 Europe Bladder Disorders Market: By Type (2022-2029); Figure 35 Europe Bladder Disorders Market: Company Share 2021 (%)